• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年人接受全面药物评估的预测因素。

Predictors of Receipt of Comprehensive Medication Reviews in Older Adults.

机构信息

Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, Michigan, USA.

Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan, USA.

出版信息

J Gerontol A Biol Sci Med Sci. 2023 Mar 1;78(3):463-469. doi: 10.1093/gerona/glac096.

DOI:10.1093/gerona/glac096
PMID:35446953
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9977218/
Abstract

BACKGROUND

Polypharmacy is highly prevalent among older adults. This study's purpose was to provide nationally representative estimates of self-reported comprehensive medication review (CMR) receipt among older adults and describe factors associated with their receipt, as CMRs are available through the Medicare Part D program.

METHODS

This cross-sectional study used data from the National Poll on Healthy Aging (NPHA), a nationally representative online survey of community-dwelling adults aged 50-80, administered in December 2019. Participants included older adults aged 65-80 with any health insurance (n = 960). Outcomes were self-reported CMR receipt, awareness of CMR insurance coverage, and interest in a future CMR with a pharmacist. Sociodemographic and health-related variables were included. Descriptive statistics and multivariable logistic regression with NPHA population sampling weights were used.

RESULTS

Among older adults on 2 or more prescription medications, only 20.8% had received a CMR while 34.3% were interested in a future CMR. Among individuals who had not received a CMR, most (83.4%) were unaware their insurance might cover a CMR. Factors associated with higher odds of receiving a CMR included taking 5 or more prescription medications (adjusted odds ratio [AOR] = 2.6, 95% CI: 1.59-4.38) and reporting food insecurity (AOR = 2.9, 95% CI: 1.07-7.93). Having fair or poor self-reported physical health was associated with lower odds of receiving a CMR (AOR = 0.49, 95% CI: 0.25-0.97).

CONCLUSIONS

Most older adults on 2 or more prescription medications with health insurance had not received a CMR and many were interested in one. Targeted strategies to increase older adults' awareness and receipt of CMRs are warranted.

摘要

背景

老年人普遍存在多重用药的情况。本研究旨在提供全国范围内报告的老年人综合药物评估(CMR)接受情况的代表性估计,并描述与接受 CMR 相关的因素,因为 CMR 可通过医疗保险计划获得。

方法

这项横断面研究使用了全国健康老龄化民意调查(NPHA)的数据,这是一项针对年龄在 50-80 岁之间、居住在社区的成年人的全国性在线调查。参与者包括年龄在 65-80 岁之间、有任何医疗保险的成年人(n=960)。结果是自我报告的 CMR 接受情况、对 CMR 保险覆盖范围的认知以及对未来与药剂师进行 CMR 的兴趣。纳入了社会人口统计学和与健康相关的变量。使用 NPHA 人群抽样权重进行描述性统计和多变量逻辑回归。

结果

在服用两种或两种以上处方药的老年人中,只有 20.8%的人接受过 CMR,而 34.3%的人对未来的 CMR 感兴趣。在没有接受 CMR 的人群中,大多数(83.4%)不知道他们的保险可能涵盖 CMR。与接受 CMR 的可能性更高相关的因素包括服用 5 种或 5 种以上处方药(调整后的优势比 [AOR] = 2.6,95%置信区间:1.59-4.38)和报告食物不安全(AOR = 2.9,95%置信区间:1.07-7.93)。自我报告的身体健康状况一般或较差与接受 CMR 的可能性较低相关(AOR = 0.49,95%置信区间:0.25-0.97)。

结论

大多数有保险、服用两种或两种以上处方药的老年人尚未接受 CMR,许多人对此感兴趣。有必要采取有针对性的策略来提高老年人对 CMR 的认知和接受程度。

相似文献

1
Predictors of Receipt of Comprehensive Medication Reviews in Older Adults.老年人接受全面药物评估的预测因素。
J Gerontol A Biol Sci Med Sci. 2023 Mar 1;78(3):463-469. doi: 10.1093/gerona/glac096.
2
Patterns and predictors of older adult Medicare Part D beneficiaries' receipt of medication therapy management.老年医疗保险D部分受益人的药物治疗管理接受模式及预测因素
Res Social Adm Pharm. 2020 Sep;16(9):1208-1214. doi: 10.1016/j.sapharm.2019.12.007. Epub 2019 Dec 9.
3
Effect of Clinical and Attitudinal Characteristics on Obtaining Comprehensive Medication Reviews.临床和态度特征对获得全面药物审查的影响。
J Manag Care Spec Pharm. 2016 Apr;22(4):388-95. doi: 10.18553/jmcp.2016.22.4.388.
4
Comprehensive Medication Reviews in Long-term Care Facilities: History of Process Implementation and 2015 Results.长期护理机构的综合药物评估:实施过程的历史和 2015 年的结果。
J Manag Care Spec Pharm. 2017 Jan;23(1):22-26. doi: 10.18553/jmcp.2017.23.1.22.
5
Consumer decision making for using comprehensive medication review services.消费者使用全面药物审查服务的决策。
J Am Pharm Assoc (2003). 2019 Mar-Apr;59(2):168-177.e5. doi: 10.1016/j.japh.2018.11.003. Epub 2019 Jan 3.
6
Effects of Medicare comprehensive medication review on racial/ethnic disparities in nonadherence to statin medications among patients with Alzheimer's Disease: an observational analysis.医疗保险全面药物审查对阿尔茨海默病患者他汀类药物不依从种族/民族差异的影响:一项观察性分析。
BMC Health Serv Res. 2022 Feb 7;22(1):159. doi: 10.1186/s12913-022-07483-8.
7
Nationwide estimates of medication therapy management delivery under the Medicare prescription drug benefit.医疗保险处方药福利项下药物治疗管理服务的全国性评估。
J Am Pharm Assoc (2003). 2020 May-Jun;60(3):456-461. doi: 10.1016/j.japh.2019.12.002. Epub 2020 Jan 8.
8
A checklist for a consistent, comprehensive medication review.一份用于进行一致、全面药物评估的清单。
J Am Pharm Assoc (2003). 2023 Sep-Oct;63(5):1504-1507.e1. doi: 10.1016/j.japh.2023.06.020. Epub 2023 Jun 30.
9
Comprehensive medication review service by embedded pharmacists in primary care: Innovations and impact.基层医疗机构中嵌入药师的全面药物审查服务:创新与影响。
J Am Pharm Assoc (2003). 2022 Mar-Apr;62(2):580-587.e1. doi: 10.1016/j.japh.2021.09.015. Epub 2021 Oct 2.
10
Factors affecting Medicare Part D beneficiaries' decision to receive comprehensive medication reviews.影响 Medicare Part D 受益人的接受全面药物审查决定的因素。
J Am Pharm Assoc (2003). 2013 Sep-Oct;53(5):482-7. doi: 10.1331/JAPhA.2013.12233.

引用本文的文献

1
Pharmacoequity measurement framework: A tool to reduce health disparities.药物公平性衡量框架:一种减少健康差距的工具。
J Manag Care Spec Pharm. 2025 Feb 1;31(2):214-224. doi: 10.18553/jmcp.2025.31.2.214.
2
Applying the Andersen behavioral model to the medication therapy management program: an approach for improving medication safety in older adults.将安德森行为模型应用于药物治疗管理项目:一种提高老年人用药安全性的方法。
Front Public Health. 2024 Nov 21;12:1499362. doi: 10.3389/fpubh.2024.1499362. eCollection 2024.
3
Interest in Medication Deprescribing Among US Adults Aged 50-80.美国50至80岁成年人对减药的关注
J Gen Intern Med. 2024 Oct;39(13):2631-2633. doi: 10.1007/s11606-024-08945-x. Epub 2024 Jul 17.
4
Comprehensive Medication Review Completion Rates and Disparities After Medicare Star Rating Measure.医疗保险星级评定措施后的综合药物审查完成率及差异
JAMA Health Forum. 2024 May 3;5(5):e240807. doi: 10.1001/jamahealthforum.2024.0807.

本文引用的文献

1
Medication Costs and Use of Older Americans in Assisted Living Settings: a Nationally Representative Cross-Sectional Study.《居住在辅助生活环境中的美国老年人的药物费用和使用情况:一项全国代表性的横断面研究》。
J Gen Intern Med. 2023 Feb;38(2):294-301. doi: 10.1007/s11606-022-07434-3. Epub 2022 Feb 7.
2
Comprehensive medication review service by embedded pharmacists in primary care: Innovations and impact.基层医疗机构中嵌入药师的全面药物审查服务:创新与影响。
J Am Pharm Assoc (2003). 2022 Mar-Apr;62(2):580-587.e1. doi: 10.1016/j.japh.2021.09.015. Epub 2021 Oct 2.
3
Pharmacists providing care in statewide physician organizations: findings from the Michigan Pharmacists Transforming Care and Quality Collaborative.在全州医生组织中提供护理的药剂师:密歇根药剂师改善护理和质量合作组织的调查结果。
J Manag Care Spec Pharm. 2020 Dec;26(12):1558-1566. doi: 10.18553/jmcp.2020.26.12.1558.
4
Food insecurity is associated with multiple chronic conditions and physical health status among older US adults.在美国老年人中,粮食不安全与多种慢性疾病及身体健康状况相关。
Prev Med Rep. 2020 Dec;20:101211. doi: 10.1016/j.pmedr.2020.101211. Epub 2020 Sep 20.
5
Potentially Inappropriate Medications Are Associated with Increased Healthcare Utilization and Costs.潜在不适当用药与医疗保健利用增加和成本增加相关。
J Am Geriatr Soc. 2020 Nov;68(11):2542-2550. doi: 10.1111/jgs.16743. Epub 2020 Aug 5.
6
Original Research: The Relationship Between Food Insecurity and Cost-Related Medication Nonadherence in Older Adults: A Systematic Review.原始研究:老年人食物不安全与费用相关药物不依从性的关系:系统评价。
Am J Nurs. 2020 Jun;120(6):24-36. doi: 10.1097/01.NAJ.0000668732.28490.c1.
7
Evolution of the Medicare Part D Medication Therapy Management Program from Inception in 2006 to the Present.医疗保险D部分药物治疗管理计划从2006年设立至今的演变历程。
Am Health Drug Benefits. 2019 Sep;12(5):243-251.
8
Nationwide estimates of medication therapy management delivery under the Medicare prescription drug benefit.医疗保险处方药福利项下药物治疗管理服务的全国性评估。
J Am Pharm Assoc (2003). 2020 May-Jun;60(3):456-461. doi: 10.1016/j.japh.2019.12.002. Epub 2020 Jan 8.
9
Patterns and predictors of older adult Medicare Part D beneficiaries' receipt of medication therapy management.老年医疗保险D部分受益人的药物治疗管理接受模式及预测因素
Res Social Adm Pharm. 2020 Sep;16(9):1208-1214. doi: 10.1016/j.sapharm.2019.12.007. Epub 2019 Dec 9.
10
Consumer decision making for using comprehensive medication review services.消费者使用全面药物审查服务的决策。
J Am Pharm Assoc (2003). 2019 Mar-Apr;59(2):168-177.e5. doi: 10.1016/j.japh.2018.11.003. Epub 2019 Jan 3.